The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for SimuLab sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
SimuLab is a medical equipment company that designs, manufactures and supplies medical simulators and task trainers. The company’s product portfolio includes the TraumaMan system, pediatric surgical simulator- TraumaChild, and SonoMan and SonoMo- multi-patient platforms for learning to read diagnostic ultrasound imaging among others. The company distributes its products worldwide. SimuLab is headquartered in Seattle, Washington, the US.
The key metrics of SimuLab related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As SimuLab is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as SimuLab.
For a detailed understanding of the performance of SimuLab, buy the report here.